| |
Medical News - November 24, 2003
Antiretroviral Drugs and AIDS - The Medical News
According to the New York Times both China and
South Africa have announced plans to distribute a triple
cocktail of life-prolonging antiretroviral drugs free to
all who need it. Until recently, South Africa's top
officials have resisted these drugs because of a deep
belief, shared by others, that antiretroviral drugs are
really "poisons." Bowing to enormous international
pressure both countries have decided to invest fortunes
in drugs that do nothing to cure Aids. Lost, even to the
international press, are the lessons from California
where the history of fighting this immune disease is
oldest. "I have a large population of people who have
chosen not to take any antiretrovirals," says Donald
Abrams, M.D., director of the AIDS program at San
Francisco General Hospital. "They've watched all their
friends go on the antiviral bandwagon and die." A study
published in the New England Journal of Medicine in
1995 showed that one of the things that long-term AIDS
survivors had in commo n was that they didn't take
antiretroviral drugs.
According to the Times "both countries have now taken
a courageous and essential steps." It's comforting to
know exactly where the Times sits on this issue but
medically a case could be made that "both countries
have now taken fearful, costly, and deadly steps that
will insure AIDS suffers' will die quicker and in
increasing numbers as certain drug companies rack in
fortunes. As the market for these drugs have diminished
in the US the pharmaceutical companies have to find
other markets where the people are vulnerable to
marketing campaigns that push these drugs as a
"solution."???
Doctors who are proponents of early treatment say the
goal of antiretroviral therapy is to reduce the number of
infected cells, preserve HIV-1-specific immune
responses and possibly lower the viral set point in the
long term. What they do not commonly point out is that
such treatments serve to dramatically weaken the
immune system. Medically it makes sense to address the
risks of antiretroviral therapy including drug toxicity,
development of resistance, acute retroviral syndrome
during viral rebound and super infections that occur
during treatment interruptions.
Treatment of HIV infection is at best a complicated
balancing act between the benefits of attempted HIV
suppression and the risks of drug toxicities. More than
half the patients switch therapies within the first few
months because of side effects and roughly 20% of all
patients refuse to even begin aggressive anti viral
medical regimes due to concerns regarding the side
effects. Gastrointestinal problems are the most common
side effects of almost all antiretroviral drugs -
nucleoside analogs, NNRTIs and particularly protease
inhibitors. Typical symptoms include abdominal
discomfort, loss of appetite, diarrhea, nausea and
vomiting. Heartburn, abdominal pain, meteorism and
constipation may also occur. Nausea is a common
symptom with zidovudine-containing regimens; diarrhea
occurs frequently with zidovudine, didanosine and all
PIs, particularly nelfinavir, as well as with saquinavir
and lopinavir. In addition to the often-considerable
impact on everyday life, gastrointestinal si de effects
can lead to dehydration, malnutrition with weight loss
and low plasma drug levels and this is especially
critical in places like South Africa and certain parts of
China where malnutrition is already a main factor in
immune system failure. A number of medical people
who originally endorsed the cocktail withdrew their
support when long-term damage to the liver began
showing up and others threw in the towel when the heart
and kidneys were being damaged.
Dr. Mohammed Al-Bayati, a pathologist, said, "The
medications currently used to treat patients with AIDS,
such as AZT, protease inhibitors, and glucocorticoids,
are highly toxic. They can even cause AIDS in
asymptomatic patients, and make the disease worse in
patients with AIDS. These drugs do not have any
therapeutic value." The South African governments
resistance to these drugs was rational though not an easy
one to defend when ganged up on by the international
medical community backed to the hilt by the press.
These 'triple cocktails' are extremely toxic like
chemotherapy is for cancer patients and anyone who
reduces the reality of the tremendous risks in taking
them, even under ideal conditions, is playing people for
fools. Worse they are playing doctor, the kind with no
ethics, training or discipline. Perhaps the New York
Times should have its medical license taken away from
it since it assumes to practice medicine so
irresponsibly. It does seem that the?health departme nt
at the Times has?become?a marketing department?for
drug companies.
Medical News Editorial
http://www.worldpsychology.net |
|